|
64
|
165
|
8c19A |
Sars-cov-2 nsp3 macrodomain in complex with 1-methyl-4-[5-(morpholin-4-ylcarbonyl)-2-furyl]-1h-pyrrolo[2,3-b]pyridine |
|
82
|
298
|
8d35A |
Crystal structure of sars-cov-2 main protease (mpro) in complex with peptide from human trna methyltransferase trmt1 |
|
27
|
115
|
8c5mB |
Sars-cov-2 nsp10-16 methyltransferase in complex with mta |
|
96
|
301
|
8c5mA |
Sars-cov-2 nsp10-16 methyltransferase in complex with mta |
|
86
|
305
|
8b2tA |
Sars-cov-2 main protease (mpro) in complex with nirmatrelvir alkyne |
|
38
|
394
|
8fe4A |
Structure of dengue virus (denv2) in complex with prm13, an anti-prm monoclonal antibody |
|
9
|
81
|
8fe4B |
Structure of dengue virus (denv2) in complex with prm13, an anti-prm monoclonal antibody |
|
9
|
81
|
8fe3B |
Structure of dengue virus (denv2) in complex with prm12, an anti-prm monoclonal antibody |
|
37
|
394
|
8fe3A |
Structure of dengue virus (denv2) in complex with prm12, an anti-prm monoclonal antibody |
|
146
|
446
|
7wd4A |
Crystal structure of the ilheus virus helicase: implications for enzyme function and drug design |
|
98
|
262
|
7wnjA |
Crystal structure and cap binding analysis of the methyltransferase of langat virus |
|
84
|
306
|
7uu9A |
Crystal structure of the sars-cov-2 main protease in its apo-form |
|
84
|
306
|
7uueA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi85 |
|
87
|
306
|
7uuaA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi8 |
|
79
|
306
|
7uubA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi12 |
|
81
|
306
|
7uu7A |
Crystal structure of the sars-cov-2 main protease in its apo-form |
|
83
|
306
|
7uu6A |
Crystal structure of the sars-cov-2 main protease in its apo-form |
|
81
|
306
|
7uu8A |
Crystal structure of the sars-cov-2 main protease in its apo-form |
|
87
|
306
|
7uudA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi33 |
|
79
|
306
|
7uucA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi19 |
|
91
|
300
|
8bzvA |
Sars-cov-2 nsp10-16 methyltransferase in complex with adenosine |
|
80
|
299
|
7pzqA |
Oxidized form of sars-cov-2 main protease determined by xfel radiation |
|
34
|
133
|
7xhgA |
Crystal structure of the ntf2l domain of human g3bp1 in complex with the caprin-1 derived peptide |
|
31
|
133
|
7xhfA |
Crystal structure of the ntf2l domain of human g3bp1 in complex with the usp10 derived peptide |
|
230
|
931
|
8gwfA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
26
|
116
|
8bzvB |
Sars-cov-2 nsp10-16 methyltransferase in complex with adenosine |
|
101
|
593
|
8gwfE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
80
|
306
|
7pxzA |
Reduced form of sars-cov-2 main protease determined by xfel radiation |
|
53
|
187
|
8gwfB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwfG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
67
|
405
|
8dv6A |
Zika virus envelope protein structure in complex with a potent human mab |
|
85
|
302
|
7tekA |
Sars-cov-2 3clpro in complex with n-(4-(1h-pyrazol-4-yl)phenyl)-n-(3-chlorobenzyl)-2-(pyridin-3-yl)acetamide |
|
88
|
302
|
7telA |
Sars-cov-2 3clpro in complex with n-(4-(1h-imidazol-4-yl)phenyl)-n-(3-chloro-5-fluorobenzyl)-2-(isoquinolin-4-yl)acetamide |
|
89
|
309
|
7wfcA |
X-ray structure of hku1-plp2(cys109ser) catalytic mutant in complex with free ubiquitin |
|
36
|
181
|
8aouA |
Solution nmr structure of full-length nsp1 from sars-cov-2. |
|
86
|
305
|
7zqvA |
Structure of the sars-cov-2 main protease in complex with ag7404 |
|
25
|
94
|
8hdaA |
Crystal structure of ubl1 (residues 18-111) of sars-cov-2 |
|
77
|
305
|
7qkaA |
Crystal structure of sars-cov-2 main protease in complex with covalently bound gc376 |
|
215
|
620
|
7xd8A |
Crystal structure of dengue virus serotype 2 (denv2) polymerase elongation complex (native form) |
|
53
|
187
|
8gwiB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
230
|
931
|
8gwgA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
44
|
187
|
8gwnB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwgG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
112
|
593
|
8gwnE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
101
|
593
|
8gwgE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwiG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
184
|
926
|
8gwnA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
101
|
593
|
8gwiE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
50
|
326
|
7wutA |
Cryoem structure of stable sns1 tetramer |
|
252
|
680
|
8ejmA |
Crystal structure of human deah-box helicase dhx15 in complex with sugp1 g-patch |
